Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK3486 for induction of general anesthesia
NCT05486416Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Jan 2024
- Primary completion
- Jul 2024
- Modality
- Allosteric Modulators
- Countries
- 3
01
Overview
A Phase 3 trial of cycloprofol, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Jan 2024; status: completed.
02
Drugs
cycloprofol
Beyond the preview
Go deeper on NCT05486416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05486416.